EDGAR Filing Documents for 0001104659-23-099368

Form 8-K - Current report:

SEC Accession No. 0001104659-23-099368

Filing Date

2023-09-08

Accepted

2023-09-08 17:17:36

Documents

Period of Report

2023-09-05

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2325751d1_8k.htm iXBRL	8-K	61406
2	EXHIBIT 3.1	tm2325751d1_ex3-1.htm	EX-3.1	9733
3	EXHIBIT 3.2	tm2325751d1_ex3-2.htm	EX-3.2	5755
4	EXHIBIT 3.3	tm2325751d1_ex3-3.htm	EX-3.3	126895
5	EXHIBIT 4.1	tm2325751d1_ex4-1.htm	EX-4.1	61227
6	EXHIBIT 4.2	tm2325751d1_ex4-2.htm	EX-4.2	62606
7	EXHIBIT 10.1	tm2325751d1_ex10-1.htm	EX-10.1	375718
	Complete submission text file	0001104659-23-099368.txt		1041728

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA	clrb-20230905.xsd	EX-101.SCH	3012
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	clrb-20230905_lab.xml	EX-101.LAB	34240
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	clrb-20230905_pre.xml	EX-101.PRE	22357
12	EXTRACTED XBRL INSTANCE DOCUMENT	tm2325751d1_8k_htm.xml	XML	3320

Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932

Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120

Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)